CD8A and neoplasm: Of note, as a key regulator of anti-tumor immunity, miR-142-5p inhibited PD-L1 expression on tumor cells in vitro enhancing tumor infiltration by CD4+- and CD8+-lymphocytes (Jia et al. 2017).